APA (7th ed.) Citation

Sugimoto, H., Enomoto, T., Okuno, M., Chayahara, N., Morita, H., & Nakata, K. Drug-Induced Interstitial Lung Disease From PARP Inhibitors (Olaparib and Niraparib) for Ovarian Cancer. American College of Physicians.

Chicago Style (17th ed.) Citation

Sugimoto, Hiroshi, Takanori Enomoto, Mamoru Okuno, Naoko Chayahara, Hiroki Morita, and Kyosuke Nakata. Drug-Induced Interstitial Lung Disease From PARP Inhibitors (Olaparib and Niraparib) for Ovarian Cancer. American College of Physicians.

MLA (9th ed.) Citation

Sugimoto, Hiroshi, et al. Drug-Induced Interstitial Lung Disease From PARP Inhibitors (Olaparib and Niraparib) for Ovarian Cancer. American College of Physicians.